Balance Sheet
Cash Flow Statement
AcquisitionsCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesChange in Working CapitalExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet Equity Issued and RepurchasedNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and Equipment
Growth Metrics
Income Statement
Others
Ratios

Novartis Ag (NVSEF) Cash from Investing Activities (2016 - 2025)

Historic Cash from Investing Activities for Novartis Ag (NVSEF) over the last 17 years, with Q4 2025 value amounting to -$2.1 billion.

  • Novartis Ag's Cash from Investing Activities rose 3062.97% to -$2.1 billion in Q4 2025 from the same period last year, while for Dec 2025 it was -$4.9 billion, marking a year-over-year increase of 3508.59%. This contributed to the annual value of -$4.9 billion for FY2025, which is 3508.59% up from last year.
  • Per Novartis Ag's latest filing, its Cash from Investing Activities stood at -$2.1 billion for Q4 2025, which was up 3062.97% from -$860.0 million recorded in Q3 2025.
  • Novartis Ag's 5-year Cash from Investing Activities high stood at $10.7 billion for Q1 2023, and its period low was -$11.6 billion during Q2 2022.
  • For the 5-year period, Novartis Ag's Cash from Investing Activities averaged around -$46.2 million, with its median value being -$976.0 million (2023).
  • Within the past 5 years, the most significant YoY rise in Novartis Ag's Cash from Investing Activities was 109299.36% (2022), while the steepest drop was 1196530.61% (2022).
  • Over the past 5 years, Novartis Ag's Cash from Investing Activities (Quarter) stood at $4.6 billion in 2021, then plummeted by 132.15% to -$1.5 billion in 2022, then dropped by 19.97% to -$1.8 billion in 2023, then crashed by 72.33% to -$3.0 billion in 2024, then soared by 30.63% to -$2.1 billion in 2025.
  • Its last three reported values are -$2.1 billion in Q4 2025, -$860.0 million for Q3 2025, and -$2.2 billion during Q2 2025.